Issues‎ > ‎vol1n2‎ > ‎

sdj-10021

Priority in selection of treatment methods used for lymphatic malformations affecting maxillofacial region

Qais H. Mussa

College of Dentistry, University of Karbala

DOI: https://doi.org/10.17656/sdj.10021

Abstract

Objectives: The purpose of this paper was to discuss and evaluate the treatment plan selection and the outcomes of 82 cases of lymphatic malformation in oral & maxillofacial region.

Materials & methods:
The analysis included of 82 cases of lymphatic malformation in oral & maxillofacial region during the period between January 2004 to November 2013 at maxillofacial department in Al-Hilla General Teaching Hospital. The treatment plans selection depend on details patient history, clinical examination & imaging investigations. Different  techniques were used depended on age, extension, site & types of lymphatic malformation. The treatment methods were conservative treatment, surgery, use of sclerosing agents or combinations of them.

Results:
Total number of the patients were 82 complains from different types lymphatic malformation, 30 were males constituting 36.5% while 52 were females constituting 63.5% . The youngest patient was 5 days, while the oldest one was 45 years. Forty case treated by sclerotherapy and surgery (48.7%) . Surgery alone as primary treatment done for 27 patients (32.9%) other 10 cases treated by sclerotherapy alone   ( 12.1%) & 5 cases ( 6% )  only needs observation.

Conclusions:
Careful treatment plan selection depends on age, extension, type of lesion & experience of surgeon associated with good prognosis. Conservative resection was the most effective method in treatment of lymphatic malformation.

Keywords: Vascular malformation, lymphangioma, sclerosing agent.

References:

1.      Mulliken JB, Young A. Vascular birthmarks: hemangiomas and malformations. Philadelphia: WB Saunders; 1988.

2.      Marler JJ, Fishman SJ, Upton J, Burrows PE, Paltiel HJ, Jennings RW, et al. Prenatal diagnosis of vascular anomalies. J Pediatr Surg. 2002; 37:318–26.

3.      Lee BB, Laredo J, Lee TS, Huh S, Neville R. Terminology and classification of congenital vascular malformations. Phlebology. 2007; 22: 249-52.

4.      Mattassi R, Loose DA, Vaghi M. Hemangiomas and Vascular Malformations, An Atlas of Diagnosis and Treatment. Springer Verlag. 2009.

5.      Padwa BL, Hayward PG, Ferraro NF. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg. 1995;95:951–60.

6.      Edwards PD, Rahbar R, Ferraro NF, et al. Lymphatic malformation of the lingual base and oral floor. Plast Reconstr Surg. 2005;115:1906–15.

7.      Greene AK, Burrows PE, Smith L. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg. 2005;115:22–30.

8.      Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18:894–900.

9.      Choi DJ, Alomari AI, Chaudry G. Neurointerventional management of low-flow vascular malformations of the head and neck. Neuroimag Clin N  Am. 2009;19:199– 218.

10.    Florez-Vargas A, Vargas SO, Debelenko LV. Comparative analysis of D2–40 and LYVE-1 immunostaining in lymphatic malformations. Lymphology. 2008;41:103–10.

11.    Smith MC, Zimmerman B, Burke DK. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope. 2009;119:107–15.

12.    Burrows PE, Mitri RK, Alomari A. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol. 2008;6:209–16.

13.    Alqahtani A, Nguyen LT, Flageole H. 25 years’ experience with lymphangiomas in children. J Pediatr Surg. 1999;34:1164–8.

14.    Grimmer JF, Mulliken JB, Burrows PE, Rahbar R. Radiofrequency ablation of microcystic lymphatic malformation in the oral cavity. Arch Otolaryngol Head Neck Surg. 2006;132:1251-6.

15.    Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg. 2005;32:99–116.

16.    Raveh E, de Jong AL, Taylor GP, Forte V. Prognostic factors in the treatment of lymphatic malformations. Arch Otolaryngol Head Neck Surg. 1997;123:1061–5.

17.    Kim KH, Sung MW, Roh JL, Han MH. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg. 2004;131:307–16.

18.    Dasgupta R, Adams D, Elluru R, Wentzel MS, Azizkhan RG. Non interventional treatment of selected head and neck lymphatic malformations. J Pediatr Surg. 2008;43:869–73.